Clinical Nuclear Medicine · 2007 · 13 citations · 11 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyMetastasisCardiac ImagingCardiac Nuclear ImagingOncologic Nuclear ImagingPositron Emission TomographyThoracic Oncology ImagingTumor Imaging18F-fluorodeoxyglucose Imaging18F-fluorodeoxyglucose Positron Emission TomographyCardiac Imaging In Cardio-oncologyCardiac Mass ImagingCardiac Pet ImagingOncologic Pet ImagingPositron Emission Tomography DetectionThoracic Metastasis Imaging
Fluorodeoxyglucose (FDG) positron emission tomography (PET) has been shown to be useful in the diagnosis and staging of various malignancies. The main advantage of PET is its high sensitivity in identifying malignancies at an early stage. The authors present a patient in whom transthoracic echography and MRI revealed a right atrial mass. The diagnosis was difficult between tumor and thrombus, but PET imaging correctly suggested a malignant tumor.
11
Detection of Cardiac Myxoma by F-18 FDG PET
Denis Agostini, Gérard Babatasi, F Galateau et al. · Clinical Nuclear Medicine · 1999 · 49 citations
Visualization of myocardial metastasis of carcinoid tumor by indium-111-pentetreotide.
Henry Yeung, Massimo Imbriaco, JiaJu Zhang et al. · PubMed · 1996 · 20 citations
Medicine, Nuclear Medicine, Oncology +16